Antidiabetic medication and risk of dementia in patients with type 2 diabetes

被引：0
|
作者：
Wium-Andersen, I. K. [1 ]
Osler, M. [2 ]
Jorgensen, M. B. [1 ]
Rungby, J. [3 ]
Wium-Andersen, M. K. [2 ]
机构：
[1] Psychiat Ctr Copenhagen, Dept O, Copenhagen, Denmark
[2] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark
[3] Bispebjerg & Frederiksberg Hosp, Dept Endocrinol, Bispebjerg, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.224
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.180
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
  • [21] Antidiabetic medication, level of glycaemic control, and risk of fracture in patients with type 2 diabetes mellitus: A nested case-control study
    Charlier, Sarah H. R.
    Vavanikunnel, Janina
    Becker, Claudia
    Jick, Susan S.
    Meier, Christian
    Meier, Christoph R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 330 - 331
  • [22] Regulation occurrences of antidiabetic medication in DMP diabetes mellitus type 2 in Nordrhein
    Hass, W.
    Altenhofen, L.
    Hagen, B.
    [J]. GESUNDHEITSWESEN, 2006, 68 (07) : 468 - 469
  • [23] ANTIDIABETIC TREATMENT, OBESITY, AND CANCER RISK IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Dennouni-Medjati, N.
    Dali-Sahi, M.
    Guermouche, B.
    Boudia, H. N. Merad
    Djelti, F.
    Harek, Y.
    Kachekouche, Y.
    [J]. WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [24] Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes
    Arima, Reetta
    Marttila, Mikko
    Hautakoski, Ari
    Arffman, Martti
    Sund, Reijo
    Ilanne-Parikka, Pirjo
    Kangaskokko, Jenni
    Urpilainen, Elina
    Laara, Esa
    Hinkula, Marianne
    Puistola, Ulla
    [J]. ANTICANCER RESEARCH, 2018, 38 (07) : 4169 - 4178
  • [25] Risk of Dementia in Patients with Type 1 Diabetes mellitus
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2021, 17 (08): : 813 - 814
  • [26] Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan
    Bouchi, Ryotaro
    Sugiyama, Takehiro
    Goto, Atsushi
    Imai, Kenjiro
    Ihana-Sugiyama, Noriko
    Ohsugi, Mitsuru
    Yamauchi, Toshimasa
    Kadowaki, Takashi
    Ueki, Kohjiro
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (02) : 280 - 291
  • [27] Medication Adherence in Patients With Type 2 Diabetes
    Hennessey, Erin K.
    Peters, Golden L.
    [J]. US PHARMACIST, 2019, 44 (06) : 40 - 46
  • [28] Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients
    Tseng, Chin-Hsiao
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment
    Zheng, Bang
    Su, Bowen
    Ahmadi-Abhari, Sara
    Kapogiannis, Dimitrios
    Tzoulaki, Ioanna
    Riboli, Elio
    Middleton, Lefkos
    [J]. ALZHEIMERS & DEMENTIA, 2023, 19 (12) : 5681 - 5689
  • [30] Rosiglitazone Has a Neutral Effect on the Risk of Dementia in Type 2 Diabetes Patients
    Tseng, Chin-Hsiao
    [J]. DIABETES, 2019, 68
12345